Koroner bypass cerrahisinde aantegrad kardiyopleji yönteminin antegrad-retrograd kardiyopleji yöntemi ile inflamatuar cevap ve sol ventrikül sistolik fonksiyonları açısından kıyaslanması: prospektif randomize çalışma

Öz

Amaç: Özellikle proksimal darlığı olan koroner arter hastalarında veya ciddi miyokardiyal hipertrofisi olan hastalarda antegrad kardiyoplejinin homojen olmayan dağılımı ciddi bir problemdir. Bu prospektif randomize çalışmada, kombine antegrad-retrograd kardiyoplejinin sadece antegrad tekniğe kıyasla erken dönemde daha iyi miyokardiyal koruma sağlaması ve daha iyi laboratuar sonuçları ile ilişkisi değerlendirilmiştir.

Gereç ve Yöntemler: Koroner bypass cerrahisi uygulanan 60 hasta (45 (%75) erkek, 15 (%25) kadın) çalışmaya dahil edilmiştir ve iki grupta incelenmiştir: Grup 1’de 30 hastaya aort kökünden antegrad ve koroner sinusten retrograd yolla kombine kardiyopleji; Grup 2’de ise 30 hastaya aort kökünden antegrad kardiyopleji verildi. Preoperatif, intraoperatif ve postoperative altıncı günde alınan kan örneklerinden CK-MB, TpI, TNF- α, IL-1, IMA, ICAM-1 ve BNP parametreleri çalışıldı. Hastalar preoperative olarak ve postoperative altıncı günde transtorasik ekokardiyografi ile değerlendirildi.

Bulgular: Postoperatif ortalama EF düşüşü Grup 1’de Grup 2’ye kıyasla istatistiksel olarak anlamlı şekilde daha az oldu (4.13 ± 9.09 ve 8.90 ± 10.76, sırayla Grup 1 ve Grup 2, p=0.046). TNF- α seviyelerindeki değişimin büyüklüğü kıyaslandığında Grup 2’deki artışın daha fazla olduğu bulunmuştur (p=0.047).

Sonuçlar: Antegrad ve retrograd kardiyoplejinin birlikte uygulanmasının, erken postoperatif dönemde tek başına antegrad kardiyoplejiye göre daha iyi miyokardiyal koruma sağlayabileceği sonucuna vardık.

Anahtar Kelimeler

• antegrad,inflamasyon,kardiyopleji,miyokardiyal koruma,retrograd

Comparison of effect of antegrade with combined antegrade/retrograde cardioplegia on inflammatory response and left ventricular systolic function in coronary bypass surgery: a prospective randomized study

Öz

Aim: Nonhomogeneous distribution of antegrade cardioplegia especially in cases with severe myocardial hypertrophy or proximal stenosis of coronary arteries may be a serious problem. This prospective randomized study was designed to determine whether combined antegrade–retrograde cardioplegia provides improved myocardial protection in the early period and is associated with better laboratory results compared with antegrade technique alone.

Material and Methods: A total of 60 patients who underwent coronary artery bypass grafting surgery, 45 (75%) males and 15 (25%) females, were included in the study as 2 groups: In Group 1, 30 patients were given the combined cardioplegia solution antegrade via the aortic root and retrograde via the coronary sinus, in Group 2, 30 patients were given only antegrade cardioplegia solution via the aortic root. The CK-MB, TpI, TNF- α, IL-1, IMA, ICAM-1, and BNP parameters were studied in the blood samples which were taken preoperatively, intraoperatively and postoperative sixth day. The patients were evaluated preoperatively and on the sixth postoperative day using transthoracic echocardiography.

Results: The postoperative mean EF decrease was significantly lower in Group 1 compared to Group 2 (4.13 ± 9.09 vs 8.90 ± 10.76 in Group 1 vs. Group 2, respectively, p=0.046). When the change in TNF-α levels were compared between groups 1 and 2, the magnitude of increase in TNF-α was significantly higher in Group 2 (p=0.047).

Conclusion: We concluded that co-administration of antegrade and retrograde cardioplegia may provide improved myocardial protection compared to antegrade cardioplegia method alone in the early postoperative period.

Anahtar Kelimeler

• antegrade,cardioplegia,inflammation,myocardial protection,retrograde

Kaynakça

1. 1. Bolling SE, Flaherty JT, Bulkley BH, Gott VL, Gardner TJ. Improved myocardial preservation during global ischemia by continuous retrograde coronary sinus perfusion. J Thorac Cardiovasc Surg 1983; 86: 659-66.
2. 2. Casthely PA, Shah C, Mekhjian H et al. Left ventricular diastolic function after coronary artery bypass grafting: a correlative study with three different myocardial protection techniques. J Thorac Cardiovasc Surg 1997; 114: 254-60.
3. 3. Fabian JR, Deloche A, Swanson J, Carpentier A. Retrograde cardioplegia through the right atrium. Ann Thorac Surg 1986; 41: 101-2.
4. 4. Bhyana J, Kalmbach T, Booth FV, Mentzer M, Schimert G. Combined antegrade/retrograde cardioplegia for myocardial protection: a clinical study. J Thorac Cardiovasc Surg 1989; 98: 956-60.
5. 5. Bar-Or D, Lau E, Winkler JV. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-a preliminary report. J Emerg Med 2000; 19: 311-15.
6. 6. Fiore AC, Naunheime KS, Kaiser GC et al. Coronary sinus versus aortic root perfusion with blood cardioplegia in elective myocardial revascularization. Ann Thorac Surg 1989; 47: 684-88.
7. 7. Kulshrestha P, Rousou JA, Emgelman RM et al. Does warm blood retrograde cardioplegia preserve right ventricular function? Ann Thorac Surg 2001; 72: 1572-75.
8. 8. Flack JE 3rd, Cook JR, May SJ et al. Does cardioplegia type affect outcome and survival in patients with advanced left ventricular dysfunction? Results from the CABG Patch Trial. Circulation 2000; 102: 84–89.

9. 9. Rao V, Cohen G, Weisel RD et al. Optimal flow rates for integrated cardioplegia. J Thorac Cardiovasc Surg 1998; 115: 226-35.
10. 10. Arom KV, Emery RW, Petersen RJ, Bero JW. Evaluation of 7,000+ patients with two different routes of cardioplegia. Ann Thorac Surg 1997; 63: 1619-24.
11. 11. Aldea GS, Hou D, Fonger JD, Shemin RJ. Inhomogeneous and complementary antegrade and retrograde delivery of cardioplegic solution in the absence of coronary artery obstruction. J Thorac Cardiovasc Surg 1994; 107: 499-504.
12. 12. Jacquet L, Noirhomme P, El Khoury G et al. Cardiac troponin I as an early marker of myocardial damage after coronary bypass surgery. Eur J Cardiothorac Surg 1998; 13: 378-84.
13. 13. Kutsal A, Saydam GS, Yucel D, Balk M. Changes in serum levels of CKMB, LDH, LDH1, SGOT and myoglobin due to cardiac surgery. J Cardiovasc Surg 1991; 32: 516-21.
14. 14. Chello M, Mastroroberto P, Perticone F et al. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur J Cardiathorac Surg 2001; 20: 140-46.
15. 15. Wei CM, Heublein DM, Perrella MA et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004-9.
16. 16. Saribulbul O, Alat I, Coskun S et al. The role of brain natriuretic peptide in the prediction of cardiac performance in coronary artery bypass grafting. Tex Heart Inst J 2003; 30: 298-304.
17. 17. Song MH, Kobayashi Y, Michi H. Clinical implication of atrial and brain natriuretic peptide in coronary artery bypass grafting. Asian Cardiovasc Thorac Ann 2004; 12: 41-46.
18. 18. Matsumoto A, Hirata Y, Momomura S et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction. Am Heart J 1995; 129: 139-45.
19. 19. Yasue H, Yoshimura M, Sumida H et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.